4//SEC Filing
NPS PHARMACEUTICALS INC 4
Accession 0000890465-13-000037
CIK 0000890465operating
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 5:36 PM ET
Size
8.7 KB
Accession
0000890465-13-000037
Insider Transaction Report
Form 4
GRONINGER JAMES G
Director
Transactions
- Sale
Common Stock
2013-12-23$29.50/sh−3,000$88,500→ 750 total - Exercise/Conversion
Common Stock
2013-12-23$21.73/sh+3,000$65,190→ 3,750 total - Exercise/Conversion
Stock Options
2013-12-23−3,000→ 0 totalExercise: $21.73Exp: 2014-05-20→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 10, 2013
- [F2]On May 20, 2004, the Reporting Person received a grant of 3,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant and 2% each month thereafter. As of the date of this filing, 3,000 stock options have vested.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000890465
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 5:36 PM ET
- Size
- 8.7 KB